Jenburkt Pharma - Quaterly Results

08 Nov 2022 Evaluate
With no major difference for the quarter endedSeptember 2022 , the total revenue stood at Rs. 358.52  millions.The Net proft of the company remain more or less same to Rs. 68.67  millions from Rs. 79.70 millions ,decline by -13.84%.Operating profit for the quarter ended September 2022 decreased to 98.78 millions as compared to 114.59 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 358.52 355.08 0.97 669.84 626.88 6.85 1239.80 1092.94 13.44
Other Income 12.61 11.91 5.88 24.04 23.86 0.75 49.49 43.08 14.88
PBIDT 98.78 114.59 -13.80 182.93 180.14 1.55 322.04 241.52 33.34
Interest 0.93 1.09 -14.68 1.80 2.12 -15.09 4.35 4.74 -8.23
PBDT 97.85 113.50 -13.79 181.13 178.02 1.75 317.69 236.78 34.17
Depreciation 5.45 4.54 20.04 10.80 8.88 21.62 18.99 20.35 -6.68
PBT 92.40 108.96 -15.20 170.33 169.14 0.70 298.70 216.43 38.01
TAX 23.73 29.26 -18.90 42.13 42.93 -1.86 75.74 51.39 47.38
Deferred Tax -1.27 -0.74 71.62 -2.10 -1.35 55.56 2.96 -3.91 -175.70
PAT 68.67 79.70 -13.84 128.20 126.21 1.58 222.96 165.04 35.09
Equity 45.89 45.89 0.00 45.89 45.89 0.00 45.89 45.89 0.00
PBIDTM(%) 27.55 32.27 -14.62 27.31 28.74 -4.96 25.98 22.10 17.54

Jenburkt Pharma Share Price

1051.00 17.70 (1.71%)
29-Apr-2025 12:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1820.70
Dr. Reddys Lab 1171.70
Cipla 1546.05
Lupin 2092.50
Zydus Lifesciences 890.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...